{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:34:19Z","timestamp":1793921659946,"version":"4.8.0"},"reference-count":193,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1053\/j.semnuclmed.2013.06.003","type":"journal-article","created":{"date-parts":[[2013,10,4]],"date-time":"2013-10-04T03:16:27Z","timestamp":1380856587000},"page":"449-461","source":"Crossref","is-referenced-by-count":64,"title":["An Overview of PET Neuroimaging"],"prefix":"10.1053","volume":"43","author":[{"given":"Ilya","family":"Nasrallah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Dubroff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semnuclmed.2013.06.003_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00004728-198002000-00001","article-title":"Nuclear magnetic resonance tomography of the brain","volume":"4","author":"Holland","year":"1980","journal-title":"J Comput Assist Tomogr"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(81)90408-6","article-title":"Imaging of the brain by nuclear magnetic resonance","volume":"2","author":"Doyle","year":"1981","journal-title":"Lancet"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1148\/114.1.75","article-title":"Computed tomography with the EMI scanner in the diagnosis of primary and metastatic intracranial neoplasms","volume":"114","author":"New","year":"1975","journal-title":"Radiology"},{"issue":"4","key":"10.1053\/j.semnuclmed.2013.06.003_bib4","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2214\/ajr.124.4.643","article-title":"Cerebral infarction diagnosis by computerized tomography. Analysis and evaluation of findings","volume":"124","author":"Davis","year":"1975","journal-title":"AJR Am J Roentgenol Radium Ther Nucl Med"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib5","first-page":"190","article-title":"Measurement of local cerebral glucose metabolism in man with 18F-2-fluoro-2-deoxy-d-glucose","volume":"64","author":"Reivich","year":"1977","journal-title":"Acta Neurol Scand Suppl"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib6","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1113\/jphysiol.1890.sp000321","article-title":"On the regulation of the blood-supply of the brain","volume":"11","author":"Roy","year":"1890","journal-title":"J Physiol"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib7","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/jnnp.2003.017921","article-title":"Sir Charles Scott Sherrington (1857-1952) and the synapse","volume":"75","author":"Pearce","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib8","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000115247","article-title":"Noninvasive tomographic study of cerebral blood flow and oxygen metabolism in vivo. Potentials, limitations, and clinical applications in cerebral ischemic disorders","volume":"20","author":"Baron","year":"1981","journal-title":"Eur Neurol"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib9","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/01.STR.12.4.454","article-title":"Reversal of focal \u201cmisery-perfusion syndrome\u201d by extra-intracranial arterial bypass in hemodynamic cerebral ischemia. A case study with 15O positron emission tomography","volume":"12","author":"Baron","year":"1981","journal-title":"Stroke"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib10","doi-asserted-by":"crossref","first-page":"4230","DOI":"10.1073\/pnas.73.11.4230","article-title":"Metabolic mapping of the primary visual system of the monkey by means of the autoradiographic [14C]deoxyglucose technique","volume":"73","author":"Kennedy","year":"1976","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib11","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1113\/jphysiol.1959.sp006308","article-title":"Receptive fields of single neurones in the cat\u2019s striate cortex","volume":"148","author":"Hubel","year":"1959","journal-title":"J Physiol"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib12","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1113\/jphysiol.1962.sp006837","article-title":"Receptive fields, binocular interaction and functional architecture in the cat\u2019s visual cortex","volume":"160","author":"Hubel","year":"1962","journal-title":"J Physiol"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib13","first-page":"74","article-title":"The ocular dominance columns of the striate cortex as studied by the deoxyglucose method for measurement of local cerebral glucose utilization","volume":"100","author":"Kennedy","year":"1975","journal-title":"Trans Am Neurol Assoc"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib14","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1126\/science.414358","article-title":"Measurement of regional substrate utilization rates by emission tomography","volume":"199","author":"Raichle","year":"1978","journal-title":"Science"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib15","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1053\/snuc.2002.29270","article-title":"Initial and subsequent approach for the synthesis of 18FDG","volume":"32","author":"Fowler","year":"2002","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib16","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1126\/science.6971492","article-title":"Metabolic mapping of functional activity in human subjects with the [18F]fluorodeoxyglucose technique","volume":"212","author":"Greenberg","year":"1981","journal-title":"Science"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib17","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1212\/WNL.31.5.517","article-title":"Tomographic mapping of human cerebral metabolism visual stimulation and deprivation","volume":"31","author":"Phelps","year":"1981","journal-title":"Neurology"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib18","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1126\/science.3945811","article-title":"Maturational changes in cerebral function in infants determined by 18FDG positron emission tomography","volume":"231","author":"Chugani","year":"1986","journal-title":"Science"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib19","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/jcbfm.1982.15","article-title":"Effects of human aging on patterns of local cerebral glucose utilization determined by the [18F]fluorodeoxyglucose method","volume":"2","author":"Kuhl","year":"1982","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib20","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1126\/science.7824953","article-title":"Sex differences in regional cerebral glucose metabolism during a resting state","volume":"267","author":"Gur","year":"1995","journal-title":"Science"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib21","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/j.1471-4159.1977.tb10649.x","article-title":"The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure, and normal values in the conscious and anesthetized albino rat","volume":"28","author":"Sokoloff","year":"1977","journal-title":"J Neurochem"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib22","first-page":"E69","article-title":"Noninvasive determination of local cerebral metabolic rate of glucose in man","volume":"238","author":"Huang","year":"1980","journal-title":"Am J Physiol"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1161\/01.RES.44.1.127","article-title":"The [18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man","volume":"44","author":"Reivich","year":"1979","journal-title":"Circ Res"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/jcbfm.1983.1","article-title":"Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data","volume":"3","author":"Patlak","year":"1983","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib25","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/ana.410150302","article-title":"A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography","volume":"15","author":"Mintun","year":"1984","journal-title":"Ann Neurol"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib26","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/jcbfm.1990.127","article-title":"Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects","volume":"10","author":"Logan","year":"1990","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1471-4159.1987.tb13129.x","article-title":"Kinetic modeling of receptor-ligand binding applied to positron emission tomographic studies with neuroleptic tracers","volume":"48","author":"Logan","year":"1987","journal-title":"J Neurochem"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib28","unstructured":"Cherry SR, Sorenson J, Phelps M: Tracer kinetic modeling, in: Physics In Nuclear Medicine (ed 3). Philadelphia, PA, Saunders, 2003, pp 377-403"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib29","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/sj.jcbfm.9600493","article-title":"Consensus nomenclature for in vivo imaging of reversibly binding radioligands","volume":"27","author":"Innis","year":"2007","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib30","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1056\/NEJMra022308","article-title":"Epilepsy","volume":"349","author":"Chang","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib31","unstructured":"Linehan C, Berg AT: Epidemiologic aspect of epilepsy, in Wylie E (ed): The Treatment of Epilespy (ed 4). Philadelphia, PA, Lippincott, Williams and Wilkins, 2006"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib32","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1056\/NEJM199603073341008","article-title":"Surgery for seizures","volume":"334","author":"Engel","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib33","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.ncl.2009.06.001","article-title":"Identification of pharmacoresistant epilepsy","volume":"27","author":"Berg","year":"2009","journal-title":"Neurol Clin"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib34","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.3171\/2008.6.JNS17613","article-title":"Long-term outcome after temporal lobe epilepsy surgery in 434 consecutive adult patients","volume":"110","author":"Elsharkawy","year":"2009","journal-title":"J Neurosurg"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib35","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1053\/seiz.1999.0299","article-title":"Long-term results of vagus nerve stimulation in refractory epilepsy","volume":"8","author":"Vonck","year":"1999","journal-title":"Seizure"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib36","series-title":"Functional Cerebral SPECT and PET","first-page":"123","article-title":"Epilepsy: Positron emission tomography","author":"Theodore","year":"2010"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib37","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1528-1167.2010.02522.x","article-title":"Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005-2009","volume":"51","author":"Berg","year":"2010","journal-title":"Epilepsia"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib38","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1001\/jama.2008.771","article-title":"Epilepsy surgery for pharmacoresistant temporal lobe epilepsy: A decision analysis","volume":"300","author":"Choi","year":"2008","journal-title":"J Am Med Assoc"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib39","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1212\/01.wnl.0000319699.04265.fd","article-title":"Improvements in memory function following anterior temporal lobe resection for epilepsy","volume":"71","author":"Baxendale","year":"2008","journal-title":"Neurology"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib40","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1212\/01.wnl.0000264000.11511.30","article-title":"Worsening of quality of life after epilepsy surgery: Effect of seizures and memory decline","volume":"68","author":"Langfitt","year":"2007","journal-title":"Neurology"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib41","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1212\/01.wnl.0000259550.87773.3d","article-title":"Health care costs decline after successful epilepsy surgery","volume":"68","author":"Langfitt","year":"2007","journal-title":"Neurology"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib42","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3171\/jns.1997.87.1.0020","article-title":"A cost-effectiveness analysis of anterior temporal lobectomy for intractable temporal lobe epilepsy","volume":"87","author":"King","year":"1997","journal-title":"J Neurosurg"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib43","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ana.410080403","article-title":"Epileptic patterns of local cerebral metabolism and perfusion in humans determined by emission computed tomography of 18FDG and 13NH3","volume":"8","author":"Kuhl","year":"1980","journal-title":"Ann Neurol"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib44","first-page":"34","article-title":"Positron emission computed tomography (PECT) in refractory complex partial seizures","volume":"106","author":"Newmark","year":"1981","journal-title":"Trans Am Neurol Assoc"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib45","first-page":"52","article-title":"Epileptic patterns of local cerebral metabolism and perfusion in man: Investigation by emission computed tomography of 18F-fluorodeoxyglucose and 13N-ammonia","volume":"103","author":"Kuhl","year":"1978","journal-title":"Trans Am Neurol Assoc"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib46","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/ana.410120603","article-title":"Interictal cerebral glucose metabolism in partial epilepsy and its relation to EEG changes","volume":"12","author":"Engel","year":"1982","journal-title":"Ann Neurol"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib47","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/ana.410120604","article-title":"Pathological findings underlying focal temporal lobe hypometabolism in partial epilepsy","volume":"12","author":"Engel","year":"1982","journal-title":"Ann Neurol"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib48","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/ana.410120605","article-title":"Comparative localization of epileptic foci in partial epilepsy by PCT and EEG","volume":"12","author":"Engel","year":"1982","journal-title":"Ann Neurol"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib49","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1126\/science.6981843","article-title":"Patterns of human local cerebral glucose metabolism during epileptic seizures","volume":"218","author":"Engel","year":"1982","journal-title":"Science"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib50","series-title":"Functional Cerebral SPECT and PET Imaging","first-page":"131","article-title":"Epilepsy localization by ictal and interictal SPECT","author":"Kim","year":"2010"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib51","series-title":"Surgical Treatment of the Epilepsies","first-page":"553","article-title":"Outcome with respect to epileptic seizures","author":"Engel","year":"1987"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib52","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1212\/WNL.54.3.630","article-title":"Seizure outcome after temporal lobectomy for temporal lobe epilepsy: A Kaplan-Meier survival analysis","volume":"54","author":"Foldvary","year":"2000","journal-title":"Neurology"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib53","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1046\/j.1528-1157.2001.4220282.x","article-title":"ILAE Commission Report. Proposal for a new classification of outcome with respect to epileptic seizures following epilepsy surgery","volume":"42","author":"Wieser","year":"2001","journal-title":"Epilepsia"},{"issue":"Pt 10","key":"10.1053\/j.semnuclmed.2013.06.003_bib54","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1093\/brain\/awh257","article-title":"MRI-negative PET-positive temporal lobe epilepsy: A distinct surgically remediable syndrome","volume":"127","author":"Carne","year":"2004","journal-title":"Brain"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib55","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.yebeh.2011.08.019","article-title":"\u201cMRI-negative PET-positive\u201d temporal lobe epilepsy: Invasive EEG findings, histopathology, and postoperative outcomes","volume":"22","author":"Kuba","year":"2011","journal-title":"Epilepsy Behav"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib56","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1528-1167.2011.03359.x","article-title":"Surgical outcome in PET-positive, MRI-negative patients with temporal lobe epilepsy","volume":"53","author":"LoPinto-Khoury","year":"2012","journal-title":"Epilepsia"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib57","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1212\/WNL.0b013e31820203a9","article-title":"FDG-PET improves surgical outcome in negative MRI Taylor-type focal cortical dysplasias","volume":"75","author":"Chassoux","year":"2010","journal-title":"Neurology"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib58","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.eplepsyres.2011.08.005","article-title":"Diffusion tensor imaging can localize the epileptogenic zone in nonlesional extra-temporal refractory epilepsies when [(18)F]FDG-PET is not contributive","volume":"97","author":"Thivard","year":"2011","journal-title":"Epilepsy Res"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib59","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3171\/jns.2006.104.4.513","article-title":"Long-term outcome of epilepsy surgery among 399 patients with nonlesional seizure foci including mesial temporal lobe sclerosis","volume":"104","author":"Cohen-Gadol","year":"2006","journal-title":"J Neurosurg"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib60","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1111\/j.1528-1167.2011.03295.x","article-title":"Validation of FDG-PET\/MRI coregistration in nonlesional refractory childhood epilepsy","volume":"52","author":"Rubi","year":"2011","journal-title":"Epilepsia"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib61","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1212\/01.wnl.0000334752.41807.2f","article-title":"FDG-PET\/MRI coregistration improves detection of cortical dysplasia in patients with epilepsy","volume":"71","author":"Salamon","year":"2008","journal-title":"Neurology"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib62","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/WNP.0b013e3181fe0585","article-title":"Malformations of cortical development and aberrant cortical networks: Epileptogenesis and functional organization","volume":"27","author":"Guerrini","year":"2010","journal-title":"J Clin Neurophysiol"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib63","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1111\/j.0013-9580.2004.43303.x","article-title":"Metabolic changes of subcortical structures in intractable focal epilepsy","volume":"45","author":"Benedek","year":"2004","journal-title":"Epilepsia"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib64","first-page":"776","article-title":"Predicting seizure-free status for temporal lobe epilepsy patients undergoing surgery: Prognostic value of quantifying maximal metabolic asymmetry extending over a specified proportion of the temporal lobe","volume":"48","author":"Lin","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.seizure.2008.05.004","article-title":"Prediction of seizure outcome following epilepsy surgery: Asymmetry of thalamic glucose metabolism and cerebral neural activity in temporal lobe epilepsy","volume":"18","author":"Sakamoto","year":"2009","journal-title":"Seizure"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib66","first-page":"1964","article-title":"Ipsilateral and contralateral thalamic hypometabolism as a predictor of outcome after temporal lobectomy for seizures","volume":"41","author":"Newberg","year":"2000","journal-title":"J Nucl Med"},{"issue":"Pt 8","key":"10.1053\/j.semnuclmed.2013.06.003_bib67","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1093\/brain\/awh534","article-title":"Postoperative alteration of cerebral glucose metabolism in mesial temporal lobe epilepsy","volume":"128","author":"Joo","year":"2005","journal-title":"Brain"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib68","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1212\/WNL.0b013e3181b163a5","article-title":"Decreased GABA-A binding on FMZ-PET in succinic semialdehyde dehydrogenase deficiency","volume":"73","author":"Pearl","year":"2009","journal-title":"Neurology"},{"issue":"suppl 6","key":"10.1053\/j.semnuclmed.2013.06.003_bib69","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1111\/j.1528-1157.2000.tb01574.x","article-title":"Postlesional epilepsy: The ultimate brain plasticity","volume":"41","author":"Jacobs","year":"2000","journal-title":"Epilepsia"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib70","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0920-1211(03)00107-4","article-title":"Correlation between GABA(A) receptor density and vagus nerve stimulation in individuals with drug-resistant partial epilepsy","volume":"55","author":"Marrosu","year":"2003","journal-title":"Epilepsy Res"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib71","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.brainres.2006.09.073","article-title":"Vagus nerve stimulation may protect GABAergic neurons following traumatic brain injury in rats: An immunocytochemical study","volume":"1128","author":"Neese","year":"2007","journal-title":"Brain Res"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib72","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/neuro.02.005.2008","article-title":"Epilepsy, E\/I Balance and GABA(A) Receptor Plasticity","volume":"1","author":"Fritschy","year":"2008","journal-title":"Front Mol Neurosci"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib73","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1523\/JNEUROSCI.5050-07.2008","article-title":"The clustering of GABA(A) receptor subtypes at inhibitory synapses is facilitated via the direct binding of receptor alpha 2 subunits to gephyrin","volume":"28","author":"Tretter","year":"2008","journal-title":"J Neurosci"},{"issue":"Pt 12","key":"10.1053\/j.semnuclmed.2013.06.003_bib74","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1093\/brain\/awl287","article-title":"Altered expression of alpha3-containing GABAA receptors in the neocortex of patients with focal epilepsy","volume":"129","author":"Loup","year":"2006","journal-title":"Brain"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib75","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1089\/neu.2008.0739","article-title":"Neocortical post-traumatic epileptogenesis is associated with loss of GABAergic neurons","volume":"26","author":"Avramescu","year":"2009","journal-title":"J Neurotrauma"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib76","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0079-6123(04)47009-5","article-title":"Excitatory-inhibitory balance and critical period plasticity in developing visual cortex","volume":"147","author":"Hensch","year":"2005","journal-title":"Prog Brain Res"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.neuro.23.1.1","article-title":"Cortical and subcortical contributions to activity-dependent plasticity in primate somatosensory cortex","volume":"23","author":"Jones","year":"2000","journal-title":"Ann Rev Neurosci"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib78","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1212\/WNL.56.12.1650","article-title":"Relationship of flumazenil and glucose PET abnormalities to neocortical epilepsy surgery outcome","volume":"56","author":"Juhasz","year":"2001","journal-title":"Neurology"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib79","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1046\/j.1528-1157.2001.05401.x","article-title":"Prolonged vigabatrin treatment modifies developmental changes of GABA(A)-receptor binding in young children with epilepsy","volume":"42","author":"Juhasz","year":"2001","journal-title":"Epilepsia"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib80","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1212\/WNL.54.12.2252","article-title":"[11 C]Flumazenil binding in the medial temporal lobe in patients with temporal lobe epilepsy: Correlation with hippocampal MR volumetry, T2 relaxometry, and neuropathology","volume":"54","author":"Lamusuo","year":"2000","journal-title":"Neurology"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib81","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/ana.410400210","article-title":"Benzodiazepine receptors in focal epilepsy with cortical dysgenesis: An 11C-flumazenil PET study","volume":"40","author":"Richardson","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib82","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1136\/jnnp.57.7.797","article-title":"In vivo demonstration of altered benzodiazepine receptor density in patients with generalised epilepsy","volume":"57","author":"Savic","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib83","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s00259-005-0033-y","article-title":"Loss of neuronal integrity: A cause of hypometabolism in patients with traumatic brain injury without MRI abnormality in the chronic stage","volume":"33","author":"Shiga","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib84","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1468-1331.2002.00338.x","article-title":"Impaired benzodiazepine receptor binding in peri-lesional cortex of patients with symptomatic epilepsies studied by [(11)C]-flumazenil PET","volume":"9","author":"Szelies","year":"2002","journal-title":"Eur J Neurol"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib85","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1212\/WNL.43.10.1998","article-title":"In vivo cerebral metabolism and central benzodiazepine-receptor binding in temporal lobe epilepsy","volume":"43","author":"Henry","year":"1993","journal-title":"Neurology"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib86","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/ana.1003","article-title":"Postnatal maturation of human GABAA receptors measured with positron emission tomography","volume":"49","author":"Chugani","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib87","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/ana.410410311","article-title":"Imaging of delta- and mu-opioid receptors in temporal lobe epilepsy by positron emission tomography","volume":"41","author":"Madar","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib88","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ana.410300103","article-title":"Quantification of mu and non-mu opiate receptors in temporal lobe epilepsy using positron emission tomography","volume":"30","author":"Mayberg","year":"1991","journal-title":"Ann Neurol"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib89","first-page":"1128","article-title":"5-HT 1A receptors are reduced in temporal lobe epilepsy after partial-volume correction","volume":"46","author":"Giovacchini","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib90","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1528-1167.2008.01789.x","article-title":"18F-FCWAY and 18F-FDG PET in MRI-negative temporal lobe epilepsy","volume":"50","author":"Liew","year":"2009","journal-title":"Epilepsia"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib91","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.2967\/jnumed.112.103093","article-title":"PET of serotonin 1A receptors and cerebral glucose metabolism for temporal lobectomy","volume":"53","author":"Theodore","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib92","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1016\/j.neuroimage.2011.10.067","article-title":"Quantitative PET analyses of regional [11C]PE2I binding to the dopamine transporter--application to juvenile myoclonic epilepsy","volume":"59","author":"Odano","year":"2012","journal-title":"Neuroimage"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib93","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1528-1167.2009.02272.x","article-title":"In vivo imaging of dopamine receptors in a model of temporal lobe epilepsy","volume":"51","author":"Yakushev","year":"2010","journal-title":"Epilepsia"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib94","first-page":"540","article-title":"Involvement of the basal ganglia in refractory epilepsy: An 18F-fluoro-L-DOPA PET study using 2 methods of analysis","volume":"46","author":"Bouilleret","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib95","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/01.wnl.0000297514.47695.48","article-title":"Basal ganglia involvement in temporal lobe epilepsy: A functional and morphologic study","volume":"70","author":"Bouilleret","year":"2008","journal-title":"Neurology"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib96","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1212\/01.wnl.0000316192.52731.77","article-title":"Reduced striatal D1 receptor binding in autosomal dominant nocturnal frontal lobe epilepsy","volume":"71","author":"Fedi","year":"2008","journal-title":"Neurology"},{"issue":"Pt 8","key":"10.1053\/j.semnuclmed.2013.06.003_bib97","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1093\/brain\/awl156","article-title":"Alteration of the in vivo nicotinic receptor density in ADNFLE patients: A PET study","volume":"129","author":"Picard","year":"2006","journal-title":"Brain"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib98","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1528-1167.2006.00458.x","article-title":"The effect of antiepileptic drugs on 5-HT-receptor binding measured by positron emission tomography","volume":"47","author":"Theodore","year":"2006","journal-title":"Epilepsia"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib99","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1528-1167.2011.03309.x","article-title":"Serotonin 1A receptors, depression, and memory in temporal lobe epilepsy","volume":"53","author":"Theodore","year":"2012","journal-title":"Epilepsia"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib100","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1212\/01.WNL.0000049930.93113.20","article-title":"PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy","volume":"60","author":"Toczek","year":"2003","journal-title":"Neurology"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib101","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/ana.410440603","article-title":"Imaging epileptogenic tubers in children with tuberous sclerosis complex using alpha-[11C]methyl-L-tryptophan positron emission tomography","volume":"44","author":"Chugani","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib102","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.eplepsyres.2007.10.012","article-title":"Increased striatal serotonin synthesis following cortical resection in children with intractable epilepsy","volume":"78","author":"Chugani","year":"2008","journal-title":"Epilepsy Res"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib103","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1111\/j.1528-1167.2011.03103.x","article-title":"Clinical and histopathologic correlates of 11C-alpha-methyl-L-tryptophan (AMT) PET abnormalities in children with intractable epilepsy","volume":"52","author":"Chugani","year":"2011","journal-title":"Epilepsia"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib104","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1212\/WNL.57.9.1629","article-title":"Localizing value of alpha-methyl-L-tryptophan PET in intractable epilepsy of neocortical origin","volume":"57","author":"Fedi","year":"2001","journal-title":"Neurology"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib105","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1212\/01.WNL.0000049468.05050.F2","article-title":"Alpha-methyl-L-tryptophan PET detects epileptogenic cortex in children with intractable epilepsy","volume":"60","author":"Juhasz","year":"2003","journal-title":"Neurology"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib106","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.0013-9580.2004.30303.x","article-title":"Evaluation with alpha-[11C]methyl-L-tryptophan positron emission tomography for reoperation after failed epilepsy surgery","volume":"45","author":"Juhasz","year":"2004","journal-title":"Epilepsia"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib107","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1528-1167.2008.01575.x","article-title":"Alpha-[11C]methyl-L-tryptophan uptake in patients with periventricular nodular heterotopia and epilepsy","volume":"49","author":"Natsume","year":"2008","journal-title":"Epilepsia"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib108","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1212\/01.WNL.0000052682.99812.F5","article-title":"Alpha-[11C] methyl-l-tryptophan and glucose metabolism in patients with temporal lobe epilepsy","volume":"60","author":"Natsume","year":"2003","journal-title":"Neurology"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib109","doi-asserted-by":"crossref","first-page":"728","DOI":"10.2967\/jnumed.109.070920","article-title":"Evaluation of focal cortical dysplasia and mixed neuronal and glial tumors in pediatric epilepsy patients using 18F-FDG and 11C-methionine pet","volume":"51","author":"Phi","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib110","first-page":"974","article-title":"Carbon-11-methionine PET in focal cortical dysplasia: A comparison with fluorine-18-FDG PET and technetium-99m-ECD SPECT","volume":"39","author":"Sasaki","year":"1998","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib111","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.neulet.2004.12.055","article-title":"Recordings from the rat locus coeruleus during acute vagal nerve stimulation in the anaesthetised rat","volume":"379","author":"Groves","year":"2005","journal-title":"Neurosci Lett"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib112","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00004691-200109000-00002","article-title":"The mechanism of action of vagus nerve stimulation for refractory epilepsy: The current status","volume":"18","author":"Vonck","year":"2001","journal-title":"J Clin Neurophysiol"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib113","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1471-2377-9-41","article-title":"Fluorodeoxyglucose-Positron Emission Tomography in the differential diagnosis of early-onset dementia: A prospective, community-based study","volume":"9","author":"Panegyres","year":"2009","journal-title":"BMC Neurol"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib114","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1001\/jama.286.17.2120","article-title":"Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome","volume":"286","author":"Silverman","year":"2001","journal-title":"J Am Med Assoc"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2012.05.1684","article-title":"Impact of molecular imaging on the diagnostic process in a memory clinic","author":"Ossenkoppele","year":"2012","journal-title":"Alzheimer Demen"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib116","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1148\/radiol.10091402","article-title":"Relative capability of MR imaging and FDG PET to depict changes associated with prodromal and early Alzheimer disease","volume":"256","author":"Karow","year":"2010","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib117","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1073\/pnas.0709259105","article-title":"Alzheimer\u2019s disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons","volume":"105","author":"Liang","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib118","first-page":"128","article-title":"Cortical synaptic changes and gliosis in normal aging, Alzheimer\u2019s disease and frontal lobe degeneration","volume":"7","author":"Liu","year":"1996","journal-title":"Dementia"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib119","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0301-0082(98)00022-7","article-title":"Dendritic changes in Alzheimer\u2019s disease and factors that may underlie these changes","volume":"55","author":"Anderton","year":"1998","journal-title":"Prog Neurobiol"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib120","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jalz.2008.04.006","article-title":"Abnormal connectivity in the posterior cingulate and hippocampus in early Alzheimer\u2019s disease and mild cognitive impairment","volume":"4","author":"Zhou","year":"2008","journal-title":"Alzheimers Dement"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib121","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib122","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1212\/WNL.51.3.728","article-title":"The incidence of dementia: A meta-analysis","volume":"51","author":"Jorm","year":"1998","journal-title":"Neurology"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib123","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","article-title":"The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease","volume":"41","author":"Mirra","year":"1991","journal-title":"Neurology"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib124","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jalz.2010.11.006","article-title":"Sources of variability in estimates of the prevalence of Alzheimer\u2019s disease in the United States","volume":"7","author":"Wilson","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib125","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1093\/brain\/awq277","article-title":"Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer\u2019s disease","volume":"133","author":"Jack","year":"2010","journal-title":"Brain"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib126","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimer Demen"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib127","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/archneurol.2011.31","article-title":"Cognitive decline in prodromal Alzheimer disease and mild cognitive impairment","volume":"68","author":"Wilson","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib128","doi-asserted-by":"crossref","first-page":"427","DOI":"10.7326\/0003-4819-148-6-200803180-00005","article-title":"Prevalence of cognitive impairment without dementia in the United States","volume":"148","author":"Plassman","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib129","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archneur.56.3.303","article-title":"Mild cognitive impairment: Clinical characterization and outcome","volume":"56","author":"Petersen","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib130","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/S0140-6736(06)68542-5","article-title":"Mild cognitive impairment","volume":"367","author":"Gauthier","year":"2006","journal-title":"Lancet"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib131","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/clpt.2009.166","article-title":"Imaging and biomarkers in early Alzheimer\u2019s disease and mild cognitive impairment","volume":"86","author":"Petersen","year":"2009","journal-title":"Clin Pharmacol Ther"},{"issue":"suppl 1","key":"10.1053\/j.semnuclmed.2013.06.003_bib132","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.neurobiolaging.2011.09.006","article-title":"Amyloid imaging as a biomarker for cerebral beta-amyloidosis and risk prediction for Alzheimer dementia","volume":"32","author":"Klunk","year":"2011","journal-title":"Neurobiol Aging"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib133","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib134","first-page":"1920","article-title":"FDG PET imaging in patients with pathologically verified dementia","volume":"41","author":"Hoffman","year":"2000","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib135","doi-asserted-by":"crossref","first-page":"390","DOI":"10.2967\/jnumed.107.045385","article-title":"Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer\u2019s disease, and other dementias","volume":"49","author":"Mosconi","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib136","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1007\/s00259-003-1194-1","article-title":"Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer\u2019s disease: A PET follow-up study","volume":"30","author":"Drzezga","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib137","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.neurobiolaging.2009.07.002","article-title":"Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI","volume":"32","author":"Landau","year":"2011","journal-title":"Neurobiol Aging"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib138","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1148\/radiol.2311021620","article-title":"Alzheimer disease: Operating characteristics of PET\u2014A meta-analysis","volume":"231","author":"Patwardhan","year":"2004","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib139","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1212\/01.wnl.0000269790.05105.16","article-title":"What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia?","volume":"69","author":"Jagust","year":"2007","journal-title":"Neurology"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib140","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1742-1241.2011.02845.x","article-title":"Diagnostic accuracy of 18 F-FDG and 11 C-PIB-PET for prediction of short-term conversion to Alzheimer\u2019s disease in subjects with mild cognitive impairment","volume":"66","author":"Zhang","year":"2012","journal-title":"Int J Clin Pract"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib141","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1177\/1533317510363468","article-title":"The value of PET in mild cognitive impairment, typical and atypical\/unclear dementias: A retrospective memory clinic study","volume":"25","author":"Laforce","year":"2010","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib142","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1212\/WNL.0b013e3181bc010c","article-title":"Relationships between biomarkers in aging and dementia","volume":"73","author":"Jagust","year":"2009","journal-title":"Neurology"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib143","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1001\/archneurol.2011.123","article-title":"Longitudinal change of biomarkers in cognitive decline","volume":"68","author":"Lo","year":"2011","journal-title":"Arch Neurol"},{"issue":"suppl 3","key":"10.1053\/j.semnuclmed.2013.06.003_bib144","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3233\/JAD-2006-9S347","article-title":"Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the Consortium on DLB International Workshop","volume":"9","author":"McKeith","year":"2006","journal-title":"J Alzheimers Dis"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib145","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/WNL.47.5.1113","article-title":"Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop","volume":"47","author":"McKeith","year":"1996","journal-title":"Neurology"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib146","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1055\/s-2006-956754","article-title":"Dementia with Lewy bodies","volume":"27","author":"Weisman","year":"2007","journal-title":"Semin Neurol"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib147","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/ana.1133","article-title":"Alzheimer\u2019s disease versus dementia with Lewy bodies: Cerebral metabolic distinction with autopsy confirmation","volume":"50","author":"Minoshima","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib148","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1212\/WNL.58.11.1615","article-title":"The prevalence of frontotemporal dementia","volume":"58","author":"Ratnavalli","year":"2002","journal-title":"Neurology"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib149","doi-asserted-by":"crossref","first-page":"841","DOI":"10.2165\/11640070-000000000-00000","article-title":"Frontotemporal lobar degeneration: Epidemiology, pathology, diagnosis and management","volume":"26","author":"Seltman","year":"2012","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1053\/j.semnuclmed.2013.06.003_bib150","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neurobiolaging.2005.11.002","article-title":"Decline of cerebral glucose metabolism in frontotemporal dementia: A longitudinal 18F-FDG-PET-study","volume":"28","author":"Diehl-Schmid","year":"2007","journal-title":"Neurobiol Aging"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib151","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00406-010-0184-0","article-title":"A visual [18F]FDG-PET rating scale for the differential diagnosis of frontotemporal lobar degeneration","volume":"261","author":"Poljansky","year":"2011","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib152","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.neuroimage.2005.10.008","article-title":"Declarative memory impairments in Alzheimer\u2019s disease and semantic dementia","volume":"30","author":"Nestor","year":"2006","journal-title":"Neuroimage"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib153","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1001\/archneurol.2010.295","article-title":"Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors","volume":"68","author":"Womack","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib154","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1212\/WNL.54.2.447","article-title":"Prevalence and outcomes of vascular cognitive impairment. Vascular Cognitive Impairment Investigators of the Canadian Study of Health and Aging","volume":"54","author":"Rockwood","year":"2000","journal-title":"Neurology"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib155","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jns.2012.09.023","article-title":"PET imaging in the differential diagnosis of vascular dementia","volume":"322","author":"Heiss","year":"2012","journal-title":"J Neurol Sci"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib156","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1001\/archneur.1992.00530330031011","article-title":"Severity of vascular dementia is related to volume of metabolically impaired tissue","volume":"49","author":"Mielke","year":"1992","journal-title":"Arch Neurol"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib157","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/sj.jcbfm.9600296","article-title":"18FDG PET in vascular dementia: Differentiation from Alzheimer\u2019s disease using voxel-based multivariate analysis","volume":"26","author":"Kerrouche","year":"2006","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib158","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1017\/S0317167100015547","article-title":"Alzheimer\u2019s disease, cerebrovascular disease, and the beta-amyloid cascade","volume":"39","author":"Honjo","year":"2012","journal-title":"Can J Neurol Sci"},{"issue":"Pt 11","key":"10.1053\/j.semnuclmed.2013.06.003_bib159","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1093\/brain\/awm238","article-title":"Beta-amyloid imaging and memory in non-demented individuals: Evidence for preclinical Alzheimer\u2019s disease","volume":"130","author":"Pike","year":"2007","journal-title":"Brain"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib160","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer\u2019s disease with Pittsburgh Compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann Neurol"},{"issue":"Pt 6","key":"10.1053\/j.semnuclmed.2013.06.003_bib161","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1093\/brain\/awn016","article-title":"Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer\u2019s disease","volume":"131","author":"Ikonomovic","year":"2008","journal-title":"Brain"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib162","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2967\/jnumed.112.109009","article-title":"Amyloid-beta imaging with Pittsburgh compound B and florbetapir: Comparing radiotracers and quantification methods","volume":"54","author":"Landau","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib163","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1474-4422(12)70142-4","article-title":"Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-\u03b2 plaques: A prospective cohort study","volume":"11","author":"Clark","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib164","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1053\/j.semnuclmed.2011.03.001","article-title":"Florbetapir f-18: A histopathologically validated Beta-amyloid positron emission tomography imaging agent","volume":"41","author":"Lister-James","year":"2011","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib165","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.2967\/jnumed.109.065284","article-title":"Preclinical properties of 18F-AV-45: A PET agent for Abeta plaques in the brain","volume":"50","author":"Choi","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib166","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1001\/archneurol.2011.150","article-title":"Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease","volume":"68","author":"Fleisher","year":"2011","journal-title":"Arch Neurol"},{"issue":"Pt 5","key":"10.1053\/j.semnuclmed.2013.06.003_bib167","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/brain\/awp062","article-title":"Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer\u2019s disease: Implications for sequence of pathological events in Alzheimer\u2019s disease","volume":"132","author":"Jack","year":"2009","journal-title":"Brain"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib168","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12035-008-8019-y","article-title":"The ART of loss: Abeta imaging in the evaluation of Alzheimer\u2019s disease and other dementias","volume":"38","author":"Villemagne","year":"2008","journal-title":"Mol Neurobiol"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib169","doi-asserted-by":"crossref","first-page":"476","DOI":"10.2967\/jnumed.113.120618","article-title":"Appropriate Use Criteria for Amyloid PET: A Report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer\u2019s Association","volume":"54","author":"Johnson","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib170","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12603-013-0002-2","article-title":"2012: A watershed year for Alzheimer\u2019s disease research","volume":"17","author":"Grundman","year":"2013","journal-title":"J Nutr Health Aging"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib171","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1212\/WNL.0b013e3182840bbe","article-title":"Brain \u03b2-amyloid load approaches a plateau","volume":"80","author":"Jack","year":"2013","journal-title":"Neurology"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib172","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","article-title":"Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030","volume":"68","author":"Dorsey","year":"2007","journal-title":"Neurology"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib173","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson\u2019s disease: Clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib174","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/mds.22108","article-title":"Parkinson\u2019s disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: A 3-year European multicenter study with repeat [123I]FP-CIT SPECT","volume":"24","author":"Marshall","year":"2009","journal-title":"Mov Disord"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib175","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1474-4422(07)70057-1","article-title":"Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: A phase III, multicentre study","volume":"6","author":"McKeith","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib176","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1001\/archneur.61.6.919","article-title":"Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies","volume":"61","author":"O\u2019Brien","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib177","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1111\/j.1471-4159.1993.tb03521.x","article-title":"In vivo imaging of vesicular monoamine transporters in human brain using [11C]tetrabenazine and positron emission tomography","volume":"60","author":"Kilbourn","year":"1993","journal-title":"J Neurochem"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib178","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/sj.jcbfm.9600276","article-title":"Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease","volume":"26","author":"Bohnen","year":"2006","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib179","first-page":"936","article-title":"11C-DTBZ and 18F-FDG PET measures in differentiating dementias","volume":"46","author":"Koeppe","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib180","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2967\/jnumed.109.070094","article-title":"In vivo measurement of vesicular monoamine transporter type 2 density in Parkinson disease with (18)F-AV-133","volume":"51","author":"Okamura","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib181","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000334535","article-title":"Differential diagnosis in Alzheimer\u2019s disease and dementia with Lewy bodies via VMAT2 and amyloid imaging","volume":"10","author":"Villemagne","year":"2012","journal-title":"Neurodegener Dis"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib182","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1176\/appi.psy.46.3.195","article-title":"Definition, diagnosis, and forensic implications of postconcussional syndrome","volume":"46","author":"Hall","year":"2005","journal-title":"Psychosomatics"},{"issue":"Pt 1","key":"10.1053\/j.semnuclmed.2013.06.003_bib183","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/brain\/aws307","article-title":"The spectrum of disease in chronic traumatic encephalopathy","volume":"136","author":"McKee","year":"2013","journal-title":"Brain"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib184","first-page":"775","article-title":"Acute changes in regional cerebral (18)F-FDG kinetics in patients with traumatic brain injury","volume":"45","author":"Hattori","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib185","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1089\/089771504322778613","article-title":"Selective metabolic reduction in gray matter acutely following human traumatic brain injury","volume":"21","author":"Wu","year":"2004","journal-title":"J Neurotrauma"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib186","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3109\/02699059409150981","article-title":"Selected cases of poor outcome following a minor brain trauma: Comparing neuropsychological and positron emission tomography assessment","volume":"8","author":"Ruff","year":"1994","journal-title":"Brain Inj"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib187","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1176\/jnp.8.3.324","article-title":"Local cerebral glucose metabolism in patients with long-term behavioral and cognitive deficits following mild traumatic brain injury","volume":"8","author":"Gross","year":"1996","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib188","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1089\/neu.2006.0203","article-title":"Statistical image analysis of cerebral glucose metabolism in patients with cognitive impairment following diffuse traumatic brain injury","volume":"24","author":"Kato","year":"2007","journal-title":"J Neurotrauma"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib189","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1089\/neu.2011.1851","article-title":"A voxel-based analysis of FDG-PET in traumatic brain injury: Regional metabolism and relationship between the thalamus and cortical areas","volume":"28","author":"Garcia-Panach","year":"2011","journal-title":"J Neurotrauma"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib190","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2174\/1874471011104020167","article-title":"Relative hypermetabolism of vermis cerebelli in traumatic brain injured patients studied with 18FDG PET: A descriptor of brain damage and a possible predictor of outcome","volume":"4","author":"Lupi","year":"2011","journal-title":"Curr Radiopharm"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib191","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/YCO.0b013e328357b9ab","article-title":"Neuroimaging in dementias","volume":"25","author":"de Souza","year":"2012","journal-title":"Curr Opin Psychiatry"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib192","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/NEN.0b013e3181a9d503","article-title":"Chronic traumatic encephalopathy in athletes: Progressive tauopathy after repetitive head injury","volume":"68","author":"McKee","year":"2009","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1053\/j.semnuclmed.2013.06.003_bib193","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jagp.2012.11.019","article-title":"PET scanning of brain tau in retired national football league players: Preliminary findings","volume":"21","author":"Small","year":"2013","journal-title":"Am J Geriatr Psychiatry"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299813000561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299813000561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T21:42:45Z","timestamp":1688506965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299813000561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":193,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0001299813000561"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2013.06.003","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}